Evidence map›Paper›PMID 30837247›Full record

Observational studyBMJ open2019

SOBRINA Spanish study-analysing the frequency, cost and adverse events associated with overuse in primary care: protocol for a retrospective cohort study.

José Joaquín Mira, Irene Carrillo, María Teresa Gea Velázquez de Castro, Carmen Silvestre, Guadalupe Olivera, Johanna Caro-Mendivelso, Pastora Pérez-Pérez, Yolanda Agra, Ana Mª Fernández, Jesús Maria Aranaz-Andrés and 1 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03482232 (Consequences of Doing What Should Not be Done in Primary Care), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03482232 completednot on this map

Consequences of Doing What Should Not be Done in Primary Care

TypeobservationalSponsorUniversidad Miguel Hernandez de ElcheRan2018 to 2020Enrolled750,000ConditionsOverdose, Adverse EventArmsBenzodiazepines, Non-steroidal anti-inflammatory drugs, paracetamol, Antimicrobial agent, Lipid-lowering drug
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

José Joaquín MiraDepartment of Health Psychology, Universidad Miguel Hernández de Elche, Elche, Spain.
Irene CarrilloDepartment of Health Psychology, Universidad Miguel Hernández de Elche, Elche, Spain.
María Teresa Gea Velázquez de CastroServicio de Medicina Preventiva y Calidad Asistencial, Hospital Universitari Sant Joan d'Alacant, Sant Joan d'Alacant, Spain.
Carmen SilvestreServicio de Efectividad y Seguridad Asistencial, Servicio Navarro de Salud - Osasunbidea, Pamplona, Spain.
Guadalupe OliveraHospital Clínico San Carlos, Comunidad de Madrid Servicio Madrileño de Salud, Madrid, Spain.
Johanna Caro-MendivelsoAgency for Health Quality and Assessment of Catalonia (AQuAS), Barcelona, Spain.
Pastora Pérez-PérezPatient Safety Observatory, AndalusianAgency for Health Care Quality, Seville, Spain.
Yolanda AgraÁrea de Seguridad del Paciente, Ministerio de Sanidad Servicios Sociales e Igualdad, Madrid, Spain.
Ana Mª FernándezServicio de Efectividad y Seguridad Asistencial, Servicio Navarro de Salud - Osasunbidea, Pamplona, Spain.
Jesús Maria Aranaz-AndrésPreventive Medicine and Public Health, Hospital Universitario Ramón y Cajal, Madrid, Spain.
SOBRINA Research Team
Servicio Navarro de Salud · ESUniversitat de Miguel Hernández d'Elx · ESAgència de Qualitat i Avaluació Sanitàries de Catalunya · ESHospital Clínico San Carlos · ESHospital Universitari Sant Joan D'Alacant · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESMinistry of Health · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSeveral institutions and quality national agencies have fostered the creation of recommendations on what not to do to reduce overuse in clinical practice. In primary care, their impact has hardly been studied. The frequency of adverse events (AEs) associated with doing what must not be done has not been analysed, either. The aim of this study is to measure the frequency of overuse and AEs associated with doing what must not be done (commission errors) in primary care and their cost. METHODS AND ANALYSIS: A coordinated, multicentric, national project. A retrospective cohort study using computerised databases of primary care medical records from national agencies and regional health services will be conducted to analyse the frequency of the overuse due to ignore the do-not-do recommendations, and immediately afterwards, depending on their frequency, a representative random sample of medical records will be reviewed with algorithms (triggers) that determine the frequency of AEs associated with these recommendations. Cost will determine by summation of the direct costs due to the consultation, pharmacy, laboratory and imaging activities according to the cases. ETHICS AND DISSEMINATION: The study protocol has been approved by the Ethics Committee of Primary Care Research of the Valencian Community. We aim to disseminate the findings through international peer-reviewed journals and on the website (http://www.nohacer.es/). Outcomes will be used to incorporate algorithms into the electronic history to assist in making clinical decisions. TRIAL REGISTRATION NUMBER: NCT03482232; Pre-results.

Indexed as

Costs and Cost AnalysisElectronic Health RecordsHealth Care CostsHumansMedical ErrorsMedical OverusePrimary Health CareResearch DesignRetrospective StudiesSpainoverusepatient safetyprimary carequality assurancescientific societies

Identifiers

PMID30837247
PMCPMC6429720
OpenAlexW2937039316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.